Auris Medical Holding AG (NASDAQ:EARS) announced that it has completed patient enrollment in the Phase 3 TACTT3 clinical trial with Keyzilen (AM-101) in acute and post-acute inner ear tinnitus. Top-line results from the TACTT3 trial are expected in the fourth quarter of 2016.
On Tuesday Auris Medical Holding AG (NASDAQ:EARS) share price closed at $4.32. Company return on equity (ROE) is -65.80%. Auris Medical Holding AG (NASDAQ:EARS) is -45.73% away from its 52 week high.
Abraxas Petroleum Corp. (NASDAQ:AXAS)‘s stock had its “buy” rating reaffirmed by research analysts at Canaccord Genuity in a research note issued on Wednesday.
Abraxas Petroleum Corp. (NASDAQ:AXAS) traded 978430 shares and its share price advanced 3.81% to close at $1.09. Company has 2.80% insider ownership. Abraxas Petroleum Corp. (NASDAQ:AXAS) quarterly performance is 6.86% while its year to date (YTD) performance is 2.83%.
On 24 June, Pfizer Inc. (NYSE:PFE) revealed it completed its acquisition of Anacor Pharmaceuticals, Inc. According to the company, the transaction terms provided each outstanding share of Anacor to be converted into the right to get $99.25 net in cash, i.e. without any interest but subject to required withholding of taxes.
On Tuesday shares of Pfizer Inc. (NYSE:PFE) ended up at $34.44. This year Company’s Earnings per Share (EPS) growth is -21.50% and next year’s EPS growth is 7.54%. Beta of Pfizer Inc. (NYSE:PFE) is 0.85 while company weekly performance is -0.89%.
Delta Air Lines, Inc. (NYSE:DAL) said that, it Reducing capacity plan for the second half of 2016. Capacity growth slows to below 2 pct for 2H16 driven by actions across all regions. Delta Air Lines Inc says removing about 1 point of planned capacity growth for Q4 2016 to address rising fuel prices
Delta Air Lines, Inc. (NYSE:DAL) advanced 3.93% to close at $34.67 on 28 June. Its return on assets (ROA) is 8.90% while return on investment (ROI) is 27.00%. Delta Air Lines, Inc. (NYSE:DAL) price to sales (P/S) ratio is 0.66.
On 23 June, Citigroup Inc. (NYSE:C) said that, it has the capital to keep lending in a severe economic downturn, the Federal Reserve calculated Thursday in the first stage of its annual stress tests.
On 28 June Citigroup Inc. (NYSE:C) ended the day at $40.44. Company net profit margin stands at 25.70% whereas its return on equity (ROE) is 7.20%. Citigroup Inc. (NYSE:C) is -33.38% away from its 52 week high.